Fighting AMR through optimisation
Our antibiotics are rapidly becoming redundant in the face of ever more sophisticated drug resistant infections. The consequences of inaction will be nothing short of disastrous. According to official estimates, there were 52,971 antibiotic-resistant infections recorded across the UK in 2015 and 2,172 deaths.
The UK Government has launched several initiatives over the past year to fight antimicrobial resistance (AMR), the most recent of which is a new proposal that would incentivise companies to invest in new antibiotic development.
OUR UNDERWRITERS
Unrestricted financial support by:
 |
Antimicrobial Resistance Fighter Coalition |
 |
Evotec |
 |
JSS University |
 |
INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS |
Technology Database
Display your AMR Technology, Product and Service
Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.
